REMINYL 4 mg/ml, oral solution bottle, 100 ml
Active ingredients: Galantamine hydrobromide, Galantamine
Commercialized according to BDPMDispensing in France: Prescription only
Oral solutionbottle, 100 mlorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- REMINYL 4 mg/mL, solution buvable
- Pharmaceutical form
- solution buvable
- Route of administration
- orale
- Presentation description
- 1 flacon(s) en verre jaune(brun) de 100 ml avec un racleur en polyéthylène basse densité avec seringue(s) pour administration orale polyéthylène basse densité (PEBD) polystyrène avec fermeture de sécurité enfant
- Marketing authorisation holder
- JANSSEN CILAG
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 20 Nov 2025
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Requires special monitoring during treatment
- Initial prescription by a specialist
- Prescribed by specialists only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
61601453CIP73553722CIP133400935537225Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| BROMHYDRATE DE GALANTAMINEsolution | — | SA |
| GALANTAMINEsolution | 4 mg · 1 ml de solution buvable | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.